Follow-Up Study on Inflammatory Markers in CRPS1 Patients
Author Information
Author(s): Feikje Wesseldijk, Frank J. P. M. Huygen, Claudia Heijmans-Antonissen, Sjoerd P. Niehof, Freek J. Zijlstra
Primary Institution: Erasmus MC
Hypothesis
The levels of proinflammatory cytokines TNF-α and IL-6 will decline over time in patients with complex regional pain syndrome type 1 (CRPS1).
Conclusion
The study found that while levels of TNF-α and IL-6 decreased over six years, pain and other symptoms did not significantly improve.
Supporting Evidence
- Cytokine levels were significantly higher in the CRPS1 extremity compared to the contralateral extremity at earlier time points.
- Pain scores did not significantly change over the six years.
- Mobility improved significantly at the last two follow-ups.
Takeaway
Doctors looked at 12 patients with a painful condition over six years and found that some inflammation markers went down, but the pain didn't really get better.
Methodology
The study measured cytokine levels in blister fluid and assessed pain, temperature, volume, and mobility in patients at three time points over six years.
Potential Biases
Potential selection bias due to the small number of patients who participated in all follow-ups.
Limitations
The small sample size and the lack of significant improvement in pain and other symptoms limit the generalizability of the findings.
Participant Demographics
3 males and 9 females, median age 52 years at the start of the study.
Statistical Information
P-Value
p=0.028 for IL-6 decrease from T1 to T2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website